Ray Dalio’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.3M | Buy |
+34,390
| New | +$15.3M | 0.06% | 212 |
|
2025
Q1 | – | Sell |
-710
| Closed | -$286K | – | 806 |
|
2024
Q4 | $286K | Sell |
710
-2,742
| -79% | -$1.1M | ﹤0.01% | 634 |
|
2024
Q3 | $1.61M | Sell |
3,452
-29,777
| -90% | -$13.8M | 0.01% | 542 |
|
2024
Q2 | $15.6M | Sell |
33,229
-101,466
| -75% | -$47.6M | 0.08% | 187 |
|
2024
Q1 | $56.3M | Buy |
134,695
+2,341
| +2% | +$979K | 0.28% | 69 |
|
2023
Q4 | $53.9M | Sell |
132,354
-25,995
| -16% | -$10.6M | 0.3% | 65 |
|
2023
Q3 | $55.1M | Sell |
158,349
-17,964
| -10% | -$6.25M | 0.33% | 59 |
|
2023
Q2 | $62M | Sell |
176,313
-27,963
| -14% | -$9.84M | 0.38% | 54 |
|
2023
Q1 | $64.4M | Buy |
204,276
+103,457
| +103% | +$32.6M | 0.39% | 55 |
|
2022
Q4 | $29.1M | Sell |
100,819
-63,172
| -39% | -$18.2M | 0.16% | 119 |
|
2022
Q3 | $47.5M | Sell |
163,991
-53,161
| -24% | -$15.4M | 0.24% | 83 |
|
2022
Q2 | $61.2M | Buy |
217,152
+187,000
| +620% | +$52.7M | 0.26% | 80 |
|
2022
Q1 | $7.87M | Buy |
30,152
+17,735
| +143% | +$4.63M | 0.03% | 352 |
|
2021
Q4 | $2.73M | Sell |
12,417
-2,700
| -18% | -$593K | 0.02% | 420 |
|
2021
Q3 | $2.74M | Sell |
15,117
-8,139
| -35% | -$1.48M | 0.02% | 387 |
|
2021
Q2 | $4.69M | Buy |
23,256
+1,567
| +7% | +$316K | 0.03% | 341 |
|
2021
Q1 | $4.66M | Buy |
21,689
+18,059
| +497% | +$3.88M | 0.04% | 228 |
|
2020
Q4 | $858K | Buy |
+3,630
| New | +$858K | 0.01% | 405 |
|
2019
Q4 | – | Sell |
-32,260
| Closed | -$5.47M | – | 577 |
|
2019
Q3 | $5.47M | Buy |
+32,260
| New | +$5.47M | 0.05% | 137 |
|
2019
Q2 | – | Sell |
-21,889
| Closed | -$4.03M | – | 369 |
|
2019
Q1 | $4.03M | Buy |
+21,889
| New | +$4.03M | 0.02% | 155 |
|
2018
Q3 | – | Sell |
-15,509
| Closed | -$2.64M | – | 487 |
|
2018
Q2 | $2.64M | Buy |
+15,509
| New | +$2.64M | 0.03% | 181 |
|
2017
Q3 | – | Sell |
-18,673
| Closed | -$2.41M | – | 397 |
|
2017
Q2 | $2.41M | Buy |
+18,673
| New | +$2.41M | 0.02% | 156 |
|